These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8576842)

  • 1. Population pharmacokinetics of teicoplanin in patients with endocarditis.
    Yu DK; Nordbrock E; Hutcheson SJ; Lewis EW; Sullivan W; Bhargava VO; Weir SJ
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):25-39. PubMed ID: 8576842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
    Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal teicoplanin dosage regimens for methicillin-resistant Staphylococcus aureus infections in endocarditis patients and renal failure patients.
    Li N; Zhu L; Xu G; Ge T; Qi F; Li M
    J Chemother; 2017 Dec; 29(6):358-364. PubMed ID: 28587526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
    Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
    J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C-Reactive Protein in Hospitalized Patients With Gram-Positive Infections.
    Ogami C; Tsuji Y; Muraki Y; Mizoguchi A; Okuda M; To H
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):175-188. PubMed ID: 30934169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of teicoplanin in infants and children.
    Reed MD; Yamashita TS; Myers CM; Blumer JL
    J Antimicrob Chemother; 1997 Jun; 39(6):789-96. PubMed ID: 9222049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.
    Webster A; Wilson AP; Williams AH; Treasure T; Grüneberg RN
    Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin in the treatment of gram-positive-bacterial endocarditis.
    Martino P; Venditti M; Micozzi A; Brandimarte C; Gentile G; Santini C; Serra P
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1329-34. PubMed ID: 2529815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function.
    Kasai H; Tsuji Y; Hiraki Y; Tsuruyama M; To H; Yamamoto Y
    J Infect Chemother; 2018 Apr; 24(4):284-291. PubMed ID: 29292178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections.
    Wang T; Li N; Hu S; Xie J; Lei J; Wang Y; Zheng X; Xing J; Dong Y
    Int J Clin Pharmacol Ther; 2015 May; 53(5):356-62. PubMed ID: 25828639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.
    Byrne CJ; Parton T; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Enright H; Desmond R; Ryder SA; D'Arcy DM; McHugh J; Roberts JA
    J Antimicrob Chemother; 2018 Apr; 73(4):995-1003. PubMed ID: 29272419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.
    Leport C; Perronne C; Massip P; Canton P; Leclercq P; Bernard E; Lutun P; Garaud JJ; Vilde JL
    Antimicrob Agents Chemother; 1989 Jun; 33(6):871-6. PubMed ID: 2527483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study.
    Gauzit R; Kabir-Ahmadi M; Thompson N; Pea F; Tattevin P
    Int J Antimicrob Agents; 2023 Oct; 62(4):106940. PubMed ID: 37524134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study.
    Venditti M; Tarasi A; Capone A; Galié M; Menichetti F; Martino P; Serra P
    J Antimicrob Chemother; 1997 Sep; 40(3):449-52. PubMed ID: 9338503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin: a new glycopeptide antibiotic complex.
    Babul N; Pasko M
    Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic monitoring of teicoplanin in a severely burned patient].
    Lesne-Hulin A; Bourget P; Le Bever H; Ainaud P; Carsin H
    Ann Fr Anesth Reanim; 1997; 16(4):374-7. PubMed ID: 9750583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.